Since CDH1 mRNA is markedly upregulated in some types of tumors, for example, colon carcinoma (26x) and endometrial carcinoma (148x), compared to corresponding normal tissues (Fig. 1A), with further research, CDH1 mRNA levels may be established as a diagnostic biomarker for early detection of these carcinomas. Here, CDH1 is linked to endometrial carcinoma.